Understanding the Evolving Landscape of Anti-Obesity Medications (AOMs)

According to the Centers for Disease Control and Prevention, obesity continues to impact the health and well-being of 40% of U.S. adults. The need for effective treatments has never been greater. In an exclusive interview at AMCP, Shaila Yoshida, Assistant Director, Value & Access Strategy at Cencora, shares findings from her latest research into payer coverage trends for AOMs.

She discusses payers' concerns, strategies, and the transition from employer rider policies to standard commercial formularies. Shaila also highlights how real-world evidence and medical cost offsets can help shape future coverage decisions. Explore her expert insights to stay ahead in this dynamic and rapidly evolving space.